***

The Medcheck^® report provides practitioners with detailed guidelines on gene-drug interactions; highlighting potential side effects, increased toxicity, and lack of efficacy. 

President Barack Obama stated in 2015 

“What if figuring out the right dose of medicine was as simple as taking our temperature? That’s the promise of precision medicine. Delivering the right treatments, at the right time, every time to the right person” 

Nordic Laboratories is committed to deliver on Barack Obama's vision. The Future of Healthcare is now. 

The study of the relationship between genes and response to drugs has been the subject of intensive research over the past two decades. Robust evidence now exists to support testing under clinical conditions.

The Medcheck pharmacogenomics test is part of the dnalife^® portfolio of genetic tests. We analyse genotypes associated with drug responsiveness for cardiovascular disease, psychiatry and pain management amongst others. Reports provide practitioners with detailed guidelines on gene-drug interactions; highlighting potential side effects, increased toxicity, and lack of efficacy.

***

Medcheck® analyses genetic variants linked to the metabolism of the following drug classes (indicated below their respective medication areas).

Diabetes Medications:

• Meglitinides
• Sulfonylureas

Gastrointestinal Medications:

• Antiemetics
• Proton Pump Inhibitors

Infection Medications:

• Antifungals
• Antimalarial

Rheumatology Medications:

• Anti-Gout Agents
• Immunomodulators

Transplantation Medication:

• Immunosupressants

Urological Medications:

• 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
• Alpha-Blockers for Benign Prostatic Hyperplasia
• Antispasmodics for Overactive Bladder
• Phosphodiesterase Inhibitors for Erectile Dysfunction

Medcheck®: 71 genetic variations, 123 drugs

Sample required:

Blood Spot

Average processing time:

21 days